Acne Research Study
We are looking for subjects aged 9-50 years with 'acne vulgaris on the face.
What is the trial about?
In this trial, the efficacy and safety of a not yet marketed gel for the treatment of 'acne vulgaris' will be assessed in comparison to the active substance.
Meet your Investigator for this study
With you every step of your clinical trial journey, your Principal Investigator for this study is:
Dr Connor McGladdery
Clinical Research Physician
Dr. Tehmina Ahmed
Clinical Research Physician
Dr Sabrina Bhattacharya
Clinical Research Physician
Dr Karen Hopkins
Clinical Research Physician
Who can participate in the trial?
Aged 9-50 years with 'acne vulgaris' on the face
What is the study process?
The study will be approximately 16 weeks with up to 6 visits, including telephone checks.
What can you expect as compensation?
Travel expenses will be reimbursed
FAQs
How can trial participation help me and others?
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
Do you have further questions?
Please contact the respective study site(s) for questions:
Birmingham
E-mail:
birminghamclinic@futuremeds.com
Glasgow
E-mail:
info.glasgow@futuremeds.com
Liverpool
E-mail:
bridleclinic@futuremeds.com
Teesside
E-mail:
northtees@futuremeds.com
